MONTRÉAL, QC-Shire Pharma Canada ULC says it intends to relocate its current Saint-Laurent and Mississauga offices to a single location in Toronto by the fall of 2017, subject to a suitable site being secured.
As the most populous city in Canada with the largest biotech cluster in the country, the company says that Toronto provides proximity to multiple Shire stakeholders, including peer biotechnology companies and the life science communities that support them.
The decision follows the completion of its combination with Baxalta last June. Additionally, Shire is reviewing its site footprint company-wide.
There are currently 65 employees working at the Shire facilities in Saint-Laurent and 25 employees in Mississauga.